UVULOPALATOPHARYNGOPLASTY

UVULOPALATOPHARYNGOPLASTY was reported 22 times

UVULOPALATOPHARYNGOPLASTY is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Prostaglandin E1 Analog [EPC] 2 0.0001
1 Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] 1 0.0001
2 Nonergot Dopamine Agonist [EPC] 1 0.0001
3 Non-narcotic Antitussive [EPC] 1 0.0001
4 Sympathomimetic-like Agent [EPC] 1 0.0000
5 5-alpha Reductase Inhibitor [EPC] 3 0.0000
6 Central Nervous System Stimulant [EPC] 2 0.0000
7 Ester Local Anesthetic [EPC] 1 0.0000
8 Methylxanthine [EPC] 1 0.0000
9 Estrogen [EPC] 3 0.0000
10 Non-Standardized Chemical Allergen [EPC] 1 0.0000
11 Histamine-1 Receptor Antagonist [EPC] 1 0.0000
12 Amide Local Anesthetic [EPC] 1 0.0000
13 Nitrate Vasodilator [EPC] 1 0.0000
14 Partial Opioid Agonist [EPC] 1 0.0000
15 Antiarrhythmic [EPC] 1 0.0000
16 Thiazide Diuretic [EPC] 2 0.0000
17 P2Y12 Platelet Inhibitor [EPC] 1 0.0000
18 Calcineurin Inhibitor Immunosuppressant [EPC] 1 0.0000
19 Opioid Agonist [EPC] 2 0.0000
20 Progestin [EPC] 2 0.0000
21 Calcium [EPC] 1 0.0000
22 Aldosterone Antagonist [EPC] 1 0.0000
23 Janus Kinase Inhibitor [EPC] 1 0.0000
24 Platelet Aggregation Inhibitor [EPC] 3 0.0000
25 Expectorant [EPC] 1 0.0000
26 Nonsteroidal Anti-inflammatory Drug [EPC] 5 0.0000
27 Angiotensin 2 Receptor Blocker [EPC] 1 0.0000
28 Tumor Necrosis Factor Blocker [EPC] 3 0.0000
29 Benzodiazepine [EPC] 2 0.0000
30 HMG-CoA Reductase Inhibitor [EPC] 1 0.0000
31 Folate Analog Metabolic Inhibitor [EPC] 1 0.0000
32 Insulin Analog [EPC] 1 0.0000
33 Interleukin-4 Receptor alpha Antagonist [EPC] 1 0.0000